Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 19255328

Hematologic response to three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2009 Apr 10
First author
Lyons RM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Lyons RM
      type
      Author
    2. name
      Cosgriff TM
      type
      Author
    3. name
      Modi SS
      type
      Author
    4. name
      Gersh RH
      type
      Author
    5. name
      Hainsworth JD
      type
      Author
    6. name
      Cohn AL
      type
      Author
    7. name
      McIntyre HJ
      type
      Author
    8. name
      Fernando IJ
      type
      Author
    9. name
      Backstrom JT
      type
      Author
    10. name
      Beach CL
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Lyons RM
      type
      Author
    2. name
      Cosgriff TM
      type
      Author
    3. name
      Modi SS
      type
      Author
    4. name
      Gersh RH
      type
      Author
    5. name
      Hainsworth JD
      type
      Author
    6. name
      Cohn AL
      type
      Author
    7. name
      McIntyre HJ
      type
      Author
    8. name
      Fernando IJ
      type
      Author
    9. name
      Backstrom JT
      type
      Author
    10. name
      Beach CL
      type
      Author
    bibliography ids
    1. nci-bib-3364c8c3bfe47c04ad9c05fb
    book metadata
    content sha256
    182f3580261fc02b3d6358a96e86c2d5ce197155e816c23cdcc2e702e4cb6afe
    document type
    citation
    dois
    1. 10.1200/JCO.2008.17.1058
    electronic publication date
    display
    2009 Mar 2
    precision
    day
    year
    2009
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:19255328
    immutable id
    pubmed:19255328@182f3580261fc02b3d6358a96e86c2d5ce197155e816c23cdcc2e702e4cb6afe
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    11
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    1850-6
    volume
    27
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      19255328
      provenance
      batch id
      4f803f1a8e7b4f56d2f1
      provider
      NCBI PubMed ESummary
      record sha256
      5c200be1c213f719ba9f5d5d32feb1712eeb0c487d724457ee8dce5f01dfbfc7
      response sha256
      fddd7745d591ed24e15d20ce21f0a6c14874b8cee29153ff89c9892037c40127
      retrieved at
      2026-09-09T23:46:26.391289+00:00
      publication date
      display
      2009 Apr 10
      precision
      day
      year
      2009
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/19255328/
      title
      Hematologic response to three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes.

      Preserved source evidence · Not medical advice